Razelle Kurzrock, MD, is a world leader in precision medicine and immunotherapy. A board-certified medical
oncologist, practicing physician, and researcher, she serves as Associate Director of Clinical Research and of Precision Science and is the Linda T and John A Mellowes Endowed Chair of Precision Oncology at the  Medical College of Wisconsin Cancer Center. She is overseeing the development of a new Precision Medicine and Rare Cancers clinical initiative and assuming leadership of the cancer clinical trial
enterprise at the cancer center.
Dr. Kurzrock is best known for founding and chairing the largest Phase 1 clinical trials department in the world
while at the University of Texas MD Anderson Cancer Center.  She also established the Rare Tumor Clinical at the University of California, San Diego Moores Cancer Center, where she led both the Center for Personalized Cancer Therapy and Experimental
Therapeutics Program.
Dr. Kurzrock has served as principal investigator on more than 100 clinical trials and brought oversight to more
than 500 early-phase trials, with many agents yielding FDA approvals.